Exploring Metabolic Approaches for Epithelial Ovarian Cancer Therapy
Journal of Cellular Physiology · 2025
DOI: 10.1002/jcp.31495 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, 2025. Verfasst von Sangeeta Kumari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fels Cancer Institute for Personalized Medicine and Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Temple University, Phil…. Hauptthemen laut MEDLINE: Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Energy Metabolism. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 215 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Epithelial ovarian cancer (EOC) has the highest mortality rate among malignant tumors of the female reproductive system and the lowest survival rate. This poor prognosis is due to the aggressive nature of EOC, its late‐stage diagnosis, and the tumor's ability to adapt to stressors through metabolic reprogramming. EOC cells sustain their rapid proliferation by altering the uptake, utilization, and regulation of carbohydrates, lipids, and amino acids. These metabolic changes support tumor growth and contribute to metastasis, chemotherapy resistance, and immune evasion. Targeting these metabolic vulnerabilities has shown promise in preclinical studies, with some therapies advancing to clinical trials. However, challenges remain due to tumor heterogeneity, adaptive resistance mechanisms, and the influence of the tumor microenvironment. This review provides a comprehensive summary of metabolic targets for EOC treatment and offers an overview of the current landscape of clinical trials focusing on ovarian cancer metabolism. Future efforts should prioritize combination therapies that integrate metabolic inhibitors with immunotherapies or chemotherapy. Advances in precision medicine and multi‐omics approaches will be crucial for identifying patient‐specific metabolic dependencies and improving outcomes. By addressing these challenges, metabolism‐based therapies can significantly transform the treatment of this devastating disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Fels Cancer Institute for Personalized Medicine and Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
- Department of Biology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, USA.
- Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
- Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Kumari, S., Gupta, S., Jamil, A., Tabatabaei, D., & Karakashev, S. (2025). Exploring Metabolic Approaches for Epithelial Ovarian Cancer Therapy. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31495
Vancouver
Kumari S, Gupta S, Jamil A, Tabatabaei D, Karakashev S. Exploring Metabolic Approaches for Epithelial Ovarian Cancer Therapy. Journal of Cellular Physiology. 2025. doi:10.1002/jcp.31495
BibTeX
@article{Kumari2025,
author = {Kumari, Sangeeta and Gupta, Shraddha and Jamil, Aisha and Tabatabaei, Deyana and Karakashev, Sergey},
title = {Exploring Metabolic Approaches for Epithelial Ovarian Cancer Therapy},
journal = {Journal of Cellular Physiology},
year = {2025},
doi = {10.1002/jcp.31495}
}
EUVIMED